Hypertriglyceridemia clinical trials
10 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study to Assess the Safety, Tolerability and Efficacy of ION775
- A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
- A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
- Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
- A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
- Differential Thrombogenesis by EPA and DHA Mediated by HDL
- Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
- Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic Hyperlipidemia
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Hypertriglyceridemia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.